China Biologic Products Holdings Inc (CBPO)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

18TH FL, JIALONG INTERNATIONALBUILDING BEIJING, CHINA 100125

China Biologic Products Holdings, Inc. operates as a biopharmaceutical company. The Company researches, develops, and produces human plasma-based pharmaceutical and coagulation factor products in the form of tablets, injections, capsules, and syrups. China Biologic Products also distributes pharmaceutical products. China Biologic Products serves clients in China.

Data as of 2021-02-20 13:19:19 -0500
Market Cap4.707 Billion Shares Outstanding39.362 Million Avg 30-day Volume258.629 Thousand
P/E Ratio33.77195 Dividend Yield0.0 EPS3.56
Price/Sales9.11 Debt to Equity1.13 EBITDA206.042 Million
Price to Book Value2.48 Forward PE22.29 Enterprise Value3.581 Billion
Total Cash1.103 Billion Current Debt124.449 Million Gross Profit333.82 Million
BETA0.10657 52-week High/Low120.01 / 97.91 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CBPO instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 6 -16.67% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 87 87 0.0% 27 (1.63%) 28 (1.74%) -3.57%
13F shares: 13.871 Million 13.685 Million 1.36% 8.008 Million 7.045 Million 13.67%
% Ownership 35.7608 35.4672 0.83% 20.6467 18.2596 13.07%
New Positions: 20 14 42.86% 9 7 28.57%
Increased Positions 29 33 -12.12% 11 9 22.22%
Closed Positions 18 17 5.88% 10 13 -23.08%
Reduced Positions 27 30 -10.0% 6 11 -45.45%
Total Calls 70.1 Thousand 179.982 Thousand -61.05% 70 Thousand 137 Thousand -48.91%
Total Puts 7.608 Thousand 25.362 Thousand -70.0% 5.8 Thousand 13 Thousand -55.38%
PUT/CALL Ratio 0.11 0.14 -21.43% 0.08 0.09 -11.11%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CBPO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CBPO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LIU ZHIJING CBPO CORPORATE VICE PRESIDENT

  • Officer
4,611 2017-05-08 0

SHAO SEAN

  • Director
20,000 2017-03-01 0

GAO DAVID CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
395,347 2017-02-28 0

YEUNG ALBERT

  • Director
45,000 2016-12-09 0

LIU WENFANG

  • Director
3,383 2016-08-15 0

YANG MING CHIEF FINANCIAL OFFICER

  • Officer
24,782 2016-08-15 0

YIN MING SR. CORPORATE VICE PRESIDENT

  • Officer
16,467 2016-08-15 0

YANG GANG CBPO CORPORATE VICE PRESIDENT

  • Officer
32,242 2016-08-15 0

LI DAVID HUI

  • Director
269 2016-08-11 0

FANG MIN

  • Director
7,417 2016-08-11 0

LU YUNGANG

  • Director
18,000 2016-08-04 0

TONG ZHIJUN

  • Director
12,000 2016-08-04 0

CHOW JOSEPH

  • Director
10,000 2016-08-04 0

WP X BIOLOGICS LLC

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X GP L.P.

WPP GP LLC

WARBURG PINCUS PARTNERS, L.P.

WARBURG PINCUS PARTNERS GP LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

  • Director
  • 10% Owner
No longer subject to file 2016-06-08 0

WP X BIOLOGICS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
No longer subject to file 2016-06-08 0

FENG DAI

  • Director
10,989,200 2014-05-04 0

LI BING

  • Director
5,000 2013-08-16 0

ZHANG LE

  • Director
5,000 2013-08-16 0

LI LIN LING

  • SEE REMARKS
No longer subject to file 2013-05-14 0

WP X BIOLOGICS LLC

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X LLC

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
10,989,200 2013-05-14 0

ZHAO CHAO MING PRESIDENT

  • Officer
621,787 2012-11-28 0

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X LLC

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
7,876,280 2012-06-01 0

ZHANG HAN

  • Director
0 2012-04-20 0

KUO YUYUN TRISTAN CFO

  • Officer
0 2011-12-12 0

LIN TONG JUN

  • Director
0 2011-01-01 0

CUI XIANGMIN

  • Director
0 2011-01-01 0

LI CHONG YANG

  • Director
0 2010-12-17 0

CHAN LING SIU

  • Director
  • 10% Owner
5,362,624 2010-12-13 0

KITT BARRY M

  • 10% Owner
No longer subject to file 2009-06-09 0

GAN JIE

  • Director
0 2008-07-24 0

WONG CBPO STANLEY CHIEF EXECUTIVE OFFICER

  • Officer
0 2008-05-09 0

PANG GUANG LI

  • Director
0 2008-05-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 22:15:02 UTC -0.5466 0.6166 15000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 21:45:03 UTC -0.5606 0.6306 15000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 21:15:02 UTC -0.5606 0.6306 15000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 20:45:03 UTC -0.5624 0.6324 15000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 20:15:03 UTC -0.5624 0.6324 15000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 19:45:03 UTC -0.7602 0.8302 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 19:15:03 UTC -0.7602 0.8302 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 18:45:03 UTC -0.7637 0.8337 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 18:15:02 UTC -0.7637 0.8337 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 17:45:02 UTC -0.7637 0.8337 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 17:15:03 UTC -0.7637 0.8337 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 16:45:03 UTC -0.767 0.837 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 16:15:02 UTC -0.767 0.837 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 15:45:03 UTC -0.767 0.837 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 15:15:03 UTC -0.767 0.837 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 14:45:03 UTC -1.011 1.081 350000
CHINA BIOLOGIC PRODUCTS HOLD CBPO 2021-02-26 13:00:03 UTC -1.011 1.081 350000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments